VIIA Delta 9 / CBD / CBN Dreams Sleep Gummies – 10 mg THC

Delta-9 THC at 10mg promotes sleep onset through CB1 receptor activation — reducing sleep latency (time to fall asleep) and increasing slow-wave sleep depth in the first half of the night. CBN adds its own distinct sedative dimension through separate endocannabinoid interactions that promote drowsiness and sleep maintenance. CBD moderates any THC-induced anxiety that can disrupt sleep onset in THC-sensitive consumers. Together, the three cannabinoids address sleep from three separate but complementary mechanisms — onset, depth, and anxiety reduction.

Dreams includes 10mg D9 THC alongside CBD + CBN, producing meaningful psychoactivity and deeper sleep-promoting effects than the THC-free Zen. Zen is for consumers who need THC-free sleep support (drug testing, THC sensitivity, or simply preference). Dreams is for consumers who have established THC tolerance and want the additional sleep-depth benefit that THC + CBN together provide over CBN + CBD alone. The 10mg THC in Dreams also produces the mild euphoria and physical relaxation that many consumers find beneficial for transitioning into sleep.

At 10mg D9 + CBN, some consumers may experience mild residual effects in the morning, particularly those with lower cannabis tolerance or who take the gummy with insufficient time before waking. Most regular cannabis consumers report clean morning wake-up at this dose level when taken 60–90 minutes before intended sleep. The CBD in the formula also helps moderate the next-day hangover risk that higher THC doses can produce. VIIA reports consumers finding themselves 'refreshed and recharged' — but individual metabolism varies significantly.